Human Fetal Progenitor Tenocytes for Regenerative Medicine

Area of Science:

• Regenerative Medicine
• Biotechnology
• Orthopedics

Background:

• Tendon injuries are common, with healing often resulting in scar tissue and unsatisfactory outcomes.
• Current treatments for tendon injuries have limitations, necessitating novel therapeutic approaches.
• Tissue engineering and cell therapies offer promising alternatives for tendon repair.

Purpose of the Study:

• To evaluate human fetal progenitor tenocytes (hFPTs) as a potential cell source for treating tendon injuries.
• To assess the feasibility of using hFPTs for scarless tendon regeneration.
• To determine the suitability of hFPTs for an 'off-the-shelf' cell therapy product.

Main Methods:

• Assessed the growth, phenotype stability, and karyotype of hFPTs up to passage 12.
• Investigated the ability of hFPTs to stimulate human adult tenocytes (hATs) in coculture.
• Evaluated hFPT survival and distribution within porous and gel scaffolds.

Main Results:

• hFPTs demonstrated rapid, stable growth and maintained a strong tenogenic phenotype.
• hFPTs successfully stimulated hATs, promoting extracellular matrix deposition.
• High survival rates of hFPTs were observed in various scaffold types, enabling diverse applications.

Conclusions:

• hFPTs exhibit characteristics suitable for developing an 'off-the-shelf' cell source for tendon regeneration.
• The findings support the potential of hFPTs in improving outcomes for tendon injury treatment.
• hFPTs represent a promising cell-based therapy for enhancing tendon healing and reducing fibrosis.